Meusinvest group
Meusinvest is a venture capital firm that specializes in making growth capital investments in small and medium-sized companies.
Business Model:
Revenue: $454.6k
Employees: 2-10
Rankings
Industries / Tags:
Detailed Meusinvest group Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Meusinvest is a venture capital firm that specializes in making growth capital investments in small and medium-sized companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2021 | GeneQuine Biotherapeutics GmbH | Series A | 6.6M |
| 12/2021 | EyeD Pharma | Venture Round | 0 |
| 1/2018 | Miracor Medical | Series D | 0 |
| 10/2014 | Student&a;Go | Seed Round | 159.5k |
| 2/2018 | Soundbops | Seed Round | 61.7k |
| 9/2018 | Miracor Medical | Series D | 0 |
| 7/2020 | e-peas | Venture Round | 0 |
| 7/2022 | Eclo | Series A | 0 |
| 10/2018 | Magnisense | Venture Round | 0 |
| 6/2014 | 2-Observe | Seed Round | 204.5k |
| 1/2015 | Aldento | Seed Round | 376k |
| 6/2018 | Onoff | Series A | 11.6M |
| 8/2016 | Bloomlife | Seed Round | 0 |
| 6/2021 | Amyl Therapeutics | Series A | 0 |
| 12/2015 | YouScribe | Series B | 687.5k |
| 1/2019 | Phasya | Seed Round | 0 |
| 9/2020 | Miracor Medical | Series E | 0 |
| 6/2019 | CryoTherapeutics | Series B | 0 |
| 7/2020 | ExeVir Bio | Series A | 0 |
| 7/2019 | Osivax | Series A | 9M |
| 8/2016 | Tconcept | Seed Round | 0 |
| 1/2022 | VistaCare | Venture Round | 0 |
| 2/2018 | Convert Pharmaceuticals | Series A | 0 |
| 2/2019 | Graftys | Series A | 4.7M |
| 6/2015 | Elysia | Series A | 1.3M |
| 2/2022 | Aerospacelab | Series B | 0 |
| 1/2022 | IONNYK | Series A | 1.1M |
| 7/2022 | Maana Electric | Seed Round | - |
| 1/2023 | DeuterOncology | Series A | 0 |
| 6/2006 | XDC | Series B | 0 |
| 11/2014 | Herrmutt Lobby | Venture Round | - |
| 2/2021 | Imcyse | Series B | 25.7M |
| 6/2019 | Imcyse | Series B | 31.4M |
| 2/2021 | Abscint | Seed Round | - |
| 8/2020 | Ampacimon | Venture Round | 4.7M |
| 4/2020 | Hyloris Pharmaceuticals | Venture Round | 16.4M |
| 12/2019 | Odoo | Secondary Market | 90M |
| 4/2021 | Gabi SmartCare | Series A | 0 |
| 4/2014 | Elysia | Venture Round | 692.6k |
| 7/2016 | Preesale | Seed Round | 200k |
| 9/2019 | MyCellHub | Seed Round | 0 |
| 7/2022 | Graftys | Venture Round | 2M |
| 12/2021 | PDC*line Pharma | Series B | 0 |
| 2/2020 | IVEX | Pre Seed Round | 1.3M |
| 2/2017 | Aerosint | Seed Round | 318.3k |
| 7/2022 | Graftys | Venture Round | 0 |
| 7/2022 | Maana Electric | Seed Round | - |
| 7/2022 | Eclo | Series A | 0 |
| 2/2022 | Aerospacelab | Series B | 0 |
| 1/2022 | IONNYK | Series A | 0 |
| 1/2022 | VistaCare | Venture Round | 0 |
| 12/2021 | EyeD Pharma | Venture Round | 0 |
| 12/2021 | PDC*line Pharma | Series B | 0 |
| 6/2021 | Amyl Therapeutics | Series A | 0 |
| 4/2021 | Gabi SmartCare | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
